oops see you at 15
Boehringer failed their last Phase II trial & we don't know the results for the Phase III. Its not like you can cure this disease. If anything Boehringer's drug will be late to the party with a drug which shows similar efficacy.
which would no doubt cut into any projected revenue regardless
are you saying this trial is the final pivotal study? They have 2 underway, for a reason, right? Oliver_67's comment applies....
Fact: Their phase 3 trial will be complete in Oct 2015. We won't know results until the end of next year, well after InterMune drug gets FDA approval.